At Pharmasonica, we've developed an ultrasound triggered drug delivery system targeting cancerous tumours within cancer patients. This capsular device can modulate the amount of drug administered through exogenous mechanisms, to remain non-invasive. In doing so, the drug concentration within the tumour stays within the therapeutic window to remain effective yet avoid many of the side effects that cancer patients often experience. Not only does this increase the patient's quality of life, but it also enables doctors to experience ease and convenience while using our product.
Company Details
- Employees
- 1
- Founded
- 2020
- Address
- 175 Longwood Rd S, Lower Level,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pharmasonica.com
- HQ
- Hamilton, Ontario
Pharmasonica Questions
Pharmasonica's website is pharmasonica.com
Pharmasonica's LinkedIn profile is https://ca.linkedin.com/company/pharmasonica
Pharmasonica has
1 employees.
View email and phone details for 1
employees at Pharmasonica.
Pharmasonica's industry is
Biotechnology Research
Pharmasonica's top competitors are
Organobiotech, Inc.,
Trillium Meditec,
Tolemy Bio,
Atorvia,
Acres Biosciences,
Knightlabs,
Xi Research Group (Mcmaster University),
Oligomaster,
Juncker Lab,
Department Of Molecular Genetics - University Of Toronto.
Pharmasonica's categories are Biotechnology Research
Pharmasonica's founding year is 2020
